Alexza resubmits drug application, shares soar

BANGALORE (Reuters) - Alexza Pharmaceuticals Inc said it resubmitted the approval application for its drug to calm patients with schizophrenia or bipolar disorder, sending its shares up as much as 47 percent.

donate car new jersey